
About this episode
Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures (TLV: AMDA)
While most investors have a passive role in their portfolio company, some investors are active in shaping and contributing to its success. For venture capitalists, one of the best scenarios is for the portfolio company to be acquired to maximize investment returns.
In this episode of the M&A Science Podcast, Dr. Irit Yaniv, Founding Partner and CEO at Almada Ventures, discusses what investors can do when planning and executing the exit.
____________________________________________________________________________
This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com
Episode Timestamps
00:00 Intro
03:26 M&A in the medical device industry
04:49 Minority position during Investment
05:35 When to think about an exit
06:59 Getting involved in the exit
09:57 Working with the CEO
12:03 Keeping track of potential acquisitions
14:34 Finding the right buyer
17:55 Managing exit planning disagreements
20:34 Who controls exit decisions
22:23 Negotiation
25:37 When to engage with a banker
36:51 Advice on planning an exit
38:11 Bad exits
40:29 Other takeaways
42:35 Craziest thing in M&A
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science